UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies

mAbs, 2024, Vol.16 (1), p.2324485-2324485

2024

Volltextzugriff (PDF)

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery

Proceedings of the Estonian Academy of Sciences, 2023-01, Vol.72 (4), p.371-381

Sepp, A

2023

Volltextzugriff (PDF)

Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies

Clinical and translational science, 2022-07, Vol.15 (7), p.1634-1643

2022

Volltextzugriff (PDF)

Cross-species/cross-modality physiologically based pharmacokinetics for biologics: 89Zr-labelled albumin-binding domain antibody GSK3128349 in humans

mAbs, 2020-01, Vol.12 (1), p.1832861

2020

Volltextzugriff (PDF)

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery/Bioloogiliste makromolekulide fusioloogiline farmakokineetika

Proceedings of the Estonian Academy of Sciences, 2023-12, Vol.72 (4), p.371

Sepp, Armin

2023

Volltextzugriff (PDF)

A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes

Antibodies (Basel), 2024-08, Vol.13 (3), p.70

2024

Volltextzugriff (PDF)

Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory

Journal of pharmacokinetics and pharmacodynamics, 2015-04, Vol.42 (2), p.97-109

2015

Volltextzugriff (PDF)

Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha

PloS one, 2015-02, Vol.10 (2), p.e0117847

2015

Volltextzugriff (PDF)

Cell-free Selection of Zinc Finger DNA-binding Proteins Using In Vitro Compartmentalization

Journal of molecular biology, 2005-11, Vol.354 (2), p.212-219

2005

Volltextzugriff (PDF)

Liver-targeting of interferon-alpha with tissue-specific domain antibodies

PloS one, 2013-02, Vol.8 (2), p.e57263-e57263

2013

Volltextzugriff (PDF)

The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

EJNMMI research, 2019-05, Vol.9 (1), p.45-12, Article 45

2019

Volltextzugriff (PDF)

Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation

Antibodies (Basel), 2021-10, Vol.10 (4), p.39

2021

Volltextzugriff (PDF)

Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans

Journal of pharmacokinetics and pharmacodynamics, 2022-12, Vol.49 (6), p.607-624

2022

Volltextzugriff (PDF)

Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats

Journal of pharmacokinetics and pharmacodynamics, 2019-08, Vol.46 (4), p.339-359

2019

Volltextzugriff (PDF)

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

European journal of pharmaceutical sciences, 2023-03, Vol.182, p.106375, Article 106375

2023

Volltextzugriff (PDF)

Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities

Xenobiotica, 2022-08, Vol.52 (8), p.840-854

2022

Volltextzugriff (PDF)

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys

European journal of nuclear medicine and molecular imaging, 2023-02, Vol.50 (3), p.667-678

2023

Volltextzugriff (PDF)

Next generation immunotherapeutics—honing the magic bullet

Current opinion in biotechnology, 2009-08, Vol.20 (4), p.405-411

2009

Volltextzugriff (PDF)

Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion

mAbs, 2016-07, Vol.8 (5), p.905-915

2016

Volltextzugriff (PDF)

Cell-free selection of domain antibodies by in vitro compartmentalization

Methods in molecular biology (Clifton, N.J.), 2012, Vol.911, p.183

2012

Volltextzugriff (PDF)

Microbead display by in vitro compartmentalisation: selection for binding using flow cytometry

FEBS letters, 2002-12, Vol.532 (3), p.455-458

2002

Volltextzugriff (PDF)

Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity

Journal of immunological methods, 1996-09, Vol.196 (2), p.175-180

1996

Volltextzugriff (PDF)

Perfusion and Permeability-Limited Distribution Models

The Art and Science of Physiologically-Based Pharmacokinetics Modeling, 2025, p.90-117

1, 2025

Volltextzugriff (PDF)

CELL-FREE SELECTION OF DNA-BINDING PROTEINS FOR FUTURE GENE THERAPY APPLICATIONS

Gene therapy and regulation, 2007-03, Vol.3 (1), p.51-63

2007

Volltextzugriff (PDF)

Cross-species/cross-modality physiologically based pharmacokinetics for biologics: 89Zr-labelled albumin-binding domain antibody GSK3128349 in humans

mAbs, 2020, Vol.12 (1)

2020

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(40)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(12)
Animals
(11)
Biochemistry & Molecular Biology
(10)
Pharmacokinetics
(10)
Proteins
(8)
Monoclonal Antibodies
(7)
Kinetics
(6)
Pharmacology & Pharmacy
(6)
Physiologically Based Pharmacokinetics
(6)
Biological And Medical Sciences
(5)
Domain Antibody
(5)
Medicine
(5)
Models, Biological
(5)
Pharmacodynamics
(5)
Albudab
(4)
Albumin
(4)
Amino Acid Sequence
(4)
Antibody
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Application of quantitative protein mass spectrometric data in the early predictive analysis of membrane-bound target engagement by monoclonal antibodies

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery

Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies

Cross-species/cross-modality physiologically based pharmacokinetics for biologics: 89Zr-labelled albumin-binding domain antibody GSK3128349 in humans

Predictive modelling and simulation for taming the chance and luck in biologics drug discovery/Bioloogiliste makromolekulide fusioloogiline farmakokineetika

A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes

Development of a physiologically based pharmacokinetic model for a domain antibody in mice using the two-pore theory

Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha

Cell-free Selection of Zinc Finger DNA-binding Proteins Using In Vitro Compartmentalization

Liver-targeting of interferon-alpha with tissue-specific domain antibodies

The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans

Novel Selection Approaches to Identify Antibodies Targeting Neoepitopes on the C5b6 Intermediate Complex to Inhibit Membrane Attack Complex Formation

Physiologically-based pharmacokinetic model for pulmonary disposition of protein therapeutics in humans

Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys

Next generation immunotherapeutics—honing the magic bullet

Modeling bispecific monoclonal antibody interaction with two cell membrane targets indicates the importance of surface diffusion

Cell-free selection of domain antibodies by in vitro compartmentalization

Microbead display by in vitro compartmentalisation: selection for binding using flow cytometry

Improved protocol for colorimetric detection of complement-mediated cytotoxicity based on the measurement of cytoplasmic lactate dehydrogenase activity

Perfusion and Permeability-Limited Distribution Models

CELL-FREE SELECTION OF DNA-BINDING PROTEINS FOR FUTURE GENE THERAPY APPLICATIONS

Cross-species/cross-modality physiologically based pharmacokinetics for biologics: 89Zr-labelled albumin-binding domain antibody GSK3128349 in humans

Suchergebnisse filtern